Project Grant R01AI195576
Award Date 2/19/26
Completion Date 1/31/31
Dollars Obligated $572K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New Orleans, LA 70112, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tulane University $382,500 under the Allergy and Infectious Diseases Research program (CFDA 93.855) beginning August 1, 2025, with a completion date of July 31, 2030. This Project Grant funds basic immunological research investigating the regulatory mechanisms and biological functions of cyclic GMP-AMP synthase (cGAS) in the nucleus. The research deliverables encompass three primary...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $382,500 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Tulane University, effective June 20, 2025, with a completion date of May 31, 2030. This award funds fundamental biomedical research investigating the role of Taxilin Alpha (TXLNA) in cytosolic DNA-mediated innate immunity. The research addresses a significant gap in understanding how the...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Research Foundation for the State University of New York a Project Grant of $240,150 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 24, 2025, with completion scheduled for June 30, 2027. This research initiative investigates the mechanisms by which the Large Tumor-Antigen (LT) protein from polyomaviruses cooperates with the ETS1 proto-oncogene...
- Federal Grant Award Summary Award Details: The National Institute of Allergy and Infectious Diseases (NIAID) issued a $449,625 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Boston University Medical Campus, with an award date of September 11, 2025, and completion date of May 31, 2027. Research Deliverables: The grant supports structural biology research comparing the virion, nucleocapsid, and inclusion body structures of Lloviu virus (LLOV), Ebola...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $224,368 to the Regents of the University of Minnesota under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 13, 2026, with a completion date of January 31, 2028. This Project Grant supports biomedical research focused on identifying host cellular factors essential for Epstein-Barr Virus (EBV) episome persistence and maintenance within infected cells. The...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Texas Medical Branch at Galveston a Project Grant of $576,501 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, with completion scheduled for July 31, 2030. This research project investigates the previously uncharacterized role of nucleoprotein (NP) exoribonuclease in Lassa virus (LASV) replication and fitness. The award...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida a Project Grant totaling $610,971 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 3, 2026, with a completion date of January 31, 2031. This award supports investigator-initiated biomedical research focused on understanding the role of the host ubiquitin ligase CUL4B in gammaherpesvirus latency and lymphomagenesis. The...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Texas Medical Branch at Galveston a $520,128 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) beginning August 1, 2025, with completion scheduled for July 31, 2030. This research initiative investigates molecular mechanisms by which Ehrlichia chaffeensis, the causative agent of human monocytotropic ehrlichiosis, manipulates host cell RNA...
- Federal Grant Award Summary Emory University received a $922,840 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 2, 2026, through January 31, 2031. The award funds research investigating inducible hepatic-associated lymphoid tissue (IHALT) and the generation and maintenance of long-lived plasma cells (LLPCs) in response to hepatotropic viral infections. Using...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a Project Grant of $412,377 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 10, 2025, with a completion date of August 31, 2028. This R61 Phase award supports the development and optimization of in vitro cultivation systems for long-term continuous propagation of Enterocytozoon bieneusi (EB), an intracellular spore-forming...